PE  Broadfin Capital

     Office Locations:

300 Park Ave, 25th Floor
New York, NY 10022
Phone: 212-808-2460



  • Middle Market



  • Life Sciences & Healthcare
  • Medical Device



    Broadfin Capital is a global equity healthcare manager founded in 2005. Broadfin seeks to achieve mid-teen percent net returns through the consistent application of a value-oriented investment strategy based on deep, fundamental research. Drawing on its extensive research and investment experience in the medical technology, pharmaceuticals and biotechnology sectors, Broadfin's approach is differentiated by its ability to invest across all market capitalizations, a conservative approach to managing binary event risk, and focus on long-term returns.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Kevin Kotler Managing Partner, Portfolio Manager


    Portfolio companies include:


      Arch Oncology
        web link




    Recent News: